Related Experiment Video
Updated: Apr 29, 2026

Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
Improving patient outcomes following glaucoma surgery: state of the art and future perspectives
Tine Van Bergen1, Sarah Van de Velde1, Evelien Vandewalle2
1Laboratory of Ophthalmology, KU Leuven, Belgium.
Abstract:
Of all the treatments currently used to lower intraocular pressure in glaucoma patients, filtration surgery is known to be the most effective. However, in a significant percentage of cases, the constructed channel closes due to excessive scar formation, resulting in surgical failure. The process of postoperative wound healing is characterized by the coagulative and inflammatory phase, followed by the proliferative and repair phase, and finally the remodeling phase. Perioperative antimitotic agents, such as mitomycin C and 5-fluorouracil, are known to modulate the process of wound healing and to improve surgical outcome, but they carry a risk of vision-threatening complications. New alternative strategies to prevent filtration failure, such as inhibition of transforming growth factor-β, vascular endothelial growth factor, and placental growth factor, have shown promising results in the improvement of surgical success. However, it remains necessary to broaden the therapeutic approach by focusing on combined therapies and on extended drug delivery.
Insights
Glaucoma filtration surgery is effective but often fails due to scarring. New strategies targeting growth factors show promise, but combined therapies and extended drug delivery are needed for better surgical outcomes.
Area of Science:
- Ophthalmology
- Surgical Innovation
- Wound Healing Biology
Background:
- Filtration surgery is the most effective treatment for lowering intraocular pressure in glaucoma.
- Surgical failure commonly occurs due to excessive scar formation, leading to the closure of the constructed filtration channel.
- Current adjunctive treatments like mitomycin C and 5-fluorouracil improve outcomes but pose risks of vision-threatening complications.
Purpose of the Study:
- To review current and emerging strategies for preventing filtration failure after glaucoma surgery.
- To highlight the potential of novel therapeutic targets and approaches to enhance surgical success rates.
- To emphasize the need for combined therapies and advanced drug delivery systems.
Main Methods:
- Review of existing literature on glaucoma filtration surgery and wound healing.
- Analysis of the mechanisms of action for antimitotic agents and novel therapeutic targets.
- Evaluation of the efficacy and safety profiles of different treatment strategies.
Main Results:
- While antimitotic agents modulate wound healing, they are associated with severe complications.
- Inhibiting growth factors such as transforming growth factor-β, vascular endothelial growth factor, and placental growth factor shows promise in preventing filtration failure.
- Emerging strategies offer potential for improved surgical success in glaucoma patients.
Conclusions:
- Optimizing postoperative wound healing is crucial for successful glaucoma filtration surgery.
- Novel therapeutic targets beyond traditional antimitotic agents are essential for improving outcomes.
- Combined therapeutic approaches and extended drug delivery systems warrant further investigation to maximize surgical success and minimize complications.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Ophthalmic Drug Delivery Systems
